As revealed in Table 2, no statistical differences were found regarding the serological levels of WBC (P = 0.064), ESR (P = 0.272), or CRP (P = 0.330) between BO and NBO patients prior to therapy. This evidence concerns the gene CRP and bronchiolitis obliterans syndrome.